Kidney disease is one of the leading complications of diabetes, and can lead to serious health problems, including the need for dialysis or kidney transplant. Despite many medical advances that have improved diabetes treatment, kidney disease remains a problem for many people with diabetes. New treatments are urgently needed.
PERL is a clinical trial for people with type 1 diabetes who have early signs of kidney problems. Our goal is to test a new way to reduce loss of kidney function using a safe and inexpensive medicine. We are seeking adults with type 1 diabetes to participate in our study.
Join us for a conversation with Dr. Rodica Pop-Busui to learn about this study!
Sunil S. Patel, MD PhD is a board certified vitreoretinal surgeon at the West Texas Retina Consultants in Abilene. Dr. Patel attended the University of California, Los Angeles for his undergraduate education, where he studied biochemistry, and received his medical degree from the University of Texas Southwestern in Dallas. Upon completing an internship in internal medicine at the Presbyterian Hospital of Dallas, Dr. Patel completed his residency in ophthalmology at the Doheny Eye Institute-Los Angeles County Hospital at the University of Southern California. He remained at the Doheny Eye Institute for two additional years to complete a surgical and medical vitreoretinal fellowship as well as a Uveitis fellowship. Dr. Patel was a Vitreoretinal Surgeon at Texas Retina Associates until 2000, when he joined West Texas Retina Consultants as a Staff Vitreoretinal Surgeon. He also serves as an Assistant Clinical Professor in the Department of Ophthalmology at the Texas Tech University School of Medicine.
Dr. Patel received his PhD in Immunology from the University of Texas Southwestern Graduate School of Biomedical Sciences as part of the Medical Scientist Training Program. He is the President of Integrated Clinical Research, a center which conducts medical device and pharmaceutical research focused on retina and vitreous conditions.
Dr. Patel’s clinical practice focuses on the medical and surgical treatment of diseases involving vision, specifically the retina and vitreous. He is actively involved in the development of new therapeutic modalities for vitreoretinal diseases including age-related macular degeneration and diabetic macular edema. Dr. Patel is a frequent lecturer and presenter at scientific conferences and meetings and has conducted over 50 clinical research studies and authored more than 30 manuscripts.
In 2011 Teachers College Columbia University launched its solely online Master of Science in Diabetes Education and Management program. This 36-credit inter-professional master’s program is offered to clinicians who are currently in or interested in the diabetes field. As part of a course requirement, students will present ‘Master Chats’ on a variety of topics they have chosen based on discussions taking place in the tudiabetes community. Master Chats will include a 10-15 presentation followed by a Q and A.